VYNE Therapeutics Inc.
VYNE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7 | -$6 | -$9 | -$12 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1 | $1 | $1 |
| Change in WC | -$0 | -$5 | -$3 | $3 |
| Other Non-Cash | -$0 | -$0 | -$0 | -$1 |
| Operating Cash Flow | -$7 | -$11 | -$11 | -$9 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$7 | -$10 | -$14 | -$10 |
| Inv. Sales/Matur. | $11 | $14 | $34 | $23 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $4 | $5 | $20 | $13 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | $0 | -$0 | -$0 |
| Financing Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3 | -$6 | $8 | $4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22 | $28 | $20 | $16 |
| End Cash | $19 | $22 | $28 | $20 |
| Free Cash Flow | -$7 | -$11 | -$11 | -$9 |